Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herceptin monotherapy in advanced gastric cancer
NCT02005484Phase 2Terminated
- Sponsor
- Roche
- Start
- Jan 2004
- Primary completion
- Feb 2008
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of trastuzumab in gastric cancer (GC), sponsored by Roche. Started Jan 2004; status: terminated.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02005484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005484.